James N George, Sara K Vesely. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » ADAM ProteinsADAMTS13 ProteinAdultAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, Murine-DerivedAutoantibodies/immunologyCyclophosphamide/therapeutic useDrug Therapy, CombinationFemaleHumansImmunosuppressive Agents/therapeutic useMetalloendopeptidases/deficiencyPurpura, Thrombotic Thrombocytopenic/drug therapyPurpura, Thrombotic Thrombocytopenic/immunologyRecurrenceRituximabvon Willebrand Factor/metabolism
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedAutoantibodiesImmunosuppressive Agentsvon Willebrand FactorRituximabCyclophosphamideADAM ProteinsMetalloendopeptidasesADAMTS13 ProteinADAMTS13 protein, human
Year: 2003 PMID： 12529099 DOI： 10.7326/0003-4819-138-2-200301210-00018
Source DB: PubMed Journal: Ann Intern Med ISSN： 0003-4819 Impact factor: 25.391